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In Brief
Modica et al. show that upon
commitment of mesenchymal stem cells
into adipogenic lineage, Bmp4 attenuates
the acquisition and maintenance of a
brown phenotype by reducing lipolysis
and brown fat gene expression via Smad
signaling. Consequently, brown adipose
tissue function is impaired.
Cell Reports
ArticleBmp4 Promotes a Brown to
White-like Adipocyte Shift
Salvatore Modica,1 Leon G. Straub,1 Miroslav Balaz,1 Wenfei Sun,1 Lukas Varga,2,3 Patrik Stefanicka,3 Milan Profant,3
Eric Simon,6 Heike Neubauer,5 Barbara Ukropcova,2,4 Jozef Ukropec,2 and Christian Wolfrum1,7,*
1Swiss Federal Institute of Technology, Department of Health Science, Institute of Food Nutrition and Health, Laboratory of Translational
Nutrition Biology, Schwerzenbach 8603, Switzerland
2Obesity section of Diabetes Laboratory, Institute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of
Sciences, 845 05 Bratislava, Slovakia
3Department of Otorhinolaryngology–Head and Neck Surgery, Faculty of Medicine and University Hospital, Comenius University,
811 02 Bratislava, Slovakia
4Institute of Pathophysiology, Faculty of Medicine, Comenius University, 811 02 Bratislava, Slovakia
5CardioMetabolic Diseases Research, Boehringer Ingelheim Pharma, 88400 Biberach/Riss, Germany
6Target Discovery Research, Boehringer Ingelheim Pharma, 88400 Biberach/Riss, Germany
7Lead Contact
*Correspondence: christian-wolfrum@ethz.ch
http://dx.doi.org/10.1016/j.celrep.2016.07.048SUMMARY
While Bmp4 has a well-established role in the
commitment of mesenchymal stem cells into the
adipogenic lineage, its role in brown adipocyte
formation and activity is not well defined. Here, we
show that Bmp4 has a dual function in adipogenesis
by inducing adipocyte commitment while inhibiting
the acquisition of a brown phenotype during terminal
differentiation. Selective brown adipose tissue over-
expression of Bmp4 in mice induces a shift from
a brown to a white-like adipocyte phenotype. This
effect is mediated by Smad signaling and might
be in part due to suppression of lipolysis, via regula-
tion of hormone sensitive lipase expression linked
to reduced Ppar activity. Given that we observed a
strong correlation between BMP4 levels and adipo-
cyte size, as well as insulin sensitivity in humans,
we propose that Bmp4 is an important factor in the
context of obesity and type 2 diabetes.INTRODUCTION
The global obesity epidemic is currently driving a public health
crisis because of its clinical complications, such as type 2
diabetes, dyslipidemia, fatty liver, cardiovascular diseases, and
colorectal cancer. Therefore, the reduction of energy intake
and/or the increase of energy expenditure are prominent goals
to counteract obesity. In this context, two tissues play a key
role: white adipose tissue (WAT), which stores energy excess,
and brown adipose tissue (BAT), which dissipates energy as
heat by uncoupling mitochondrial respiration from ATP produc-
tion through the expression and activation of the brown fat-
specific uncoupling protein 1 (UCP1) (Aquila et al., 1985). Thus,
BAT plays a critical role in both non-shivering and diet-inducedCell Re
This is an open access article under the CC BY-Nthermogenesis to protect from not only hypothermia but also
energy overload (Bachman et al., 2002; Cannon and Neder-
gaard, 2004; Lowell et al., 1993). The presence of BAT in adult
humans was unclear until very recently, when imaging studies
revealed the existence of important depots of UCP1-expressing
adipocytes in healthy subject, whose activity was negatively
correlated with BMI (Cypess et al., 2009; Saito et al., 2009; van
Marken Lichtenbelt et al., 2009; Virtanen et al., 2009).
The development of mature adipocytes (i.e., adipogenesis) is
a complex process that can be divided into two main stages:
commitment of mesenchymal stem cells (MSCs) to pre-adipo-
cytes and terminal differentiation of pre-adipocytes to mature
adipocytes (Bachman et al., 2002; Cannon and Nedergaard,
2004; Lowell et al., 1993; Tang and Lane, 2012). The sequential
steps of the terminal differentiation phase have been widely
studied over the last years and have been subject to constant
refinement.
Bonemorphogenic proteins (BMPs) aremembers of the trans-
forming growth factor b (TGF-b) super-family that exert pleio-
tropic functions during development by regulating embryogen-
esis, organogenesis, and morphogenesis (Cypess et al., 2009;
Hogan, 1996; Saito et al., 2009; van Marken Lichtenbelt et al.,
2009; Virtanen et al., 2009). They signal through a hetero-oligo-
meric receptor complex of two types of serine-threonine kinase
receptors, namely type I and type II (Miyazono et al., 2010).
Seven type I receptor members have been identified, which
are referred to as activin-like kinase (ALK1-ALK7), while three
members of type II receptors are known (BMPR2, ACTR2, and
ACTR2B).
BMP4 signaling can be divided into two major pathways: (1)
the canonical SMAD-signaling pathway, which is transduced
by the transcription factors SMAD1,5,8 that after phosphoryla-
tion by type I receptor complex with the co-smad SMAD4 shuttle
to the nucleus to regulate gene expression; and (2) the SMAD-in-
dependent signaling pathway, which is mediated by p38, ERK,
JNK, PI3K, Rho, and microRNA (Heldin et al., 1997). Originally
identified as factors promoting bone and cartilage formation,ports 16, 2243–2258, August 23, 2016 ª 2016 The Author(s). 2243
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Bmp4 Promotes Lipid Storage and Reduces the Expression of Brown Fat Genes
(A) Qualitative analysis (cDNA) of Bmpr1a, Bmpr1b, Bmpr2, and Tbp in brown pre-adipocytes (pre-adip) and mature adipocytes (adip).
(B) qRT-PCR analysis of Bmpr1a and Bmpr2 expression during brown pre-adipocyte terminal differentiation (n = 3).
(C) Protein level quantification by western blot of pSmad1/5/8, Smad1, and g-tubulin in brown pre-adipocytes treated with different doses of Bmp4 for 1 hr.
(D) Brown pre-adipocytes were stained with oil red O 6 days after inducing adipocytes differentiation with differentiation induction medium (DIM) or after 6 days of
treatment with Bmp4 alone at different doses.
(legend continued on next page)
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BMPs were then recognized to play a key role also in the devel-
opment and function of many other tissues such as intestine,
muscle, kidney, brain, and hematopoietic tissue, as well as adi-
pose tissue (Hogan, 1996). BMP4 and BMP7 are the most-stud-
ied members in the context of adipose tissue, and BMP7 was
shown to promote the development of functional brown adipo-
cytes (Tseng et al., 2008). BMP8B has been shown to have a
role in regulating thermogenesis by increasing the response to
noradrenaline through enhanced p38MAPK/CREB signaling
and increased lipase activity (Whittle et al., 2012). Finally, growth
differentiation factor 5 (GDF5/BMP14) expression is upregulated
in obese mice to promote energy expenditure as a compensa-
tory mechanism against caloric storage (Hinoi et al., 2014).
There is strong evidence that BMP4 is important for triggering
commitment of MSCs into pre-adipocytes (Bowers et al., 2006;
Huang et al., 2009; Tang et al., 2004); however, its function dur-
ing terminal differentiation of brown fat precursor cells remains
unclear. Moreover, insights into the role of BMP4 in the meta-
bolic regulation of mature brown adipocytes are still lacking.
RESULTS
Bmp4 Impairs the Development of Functional Brown
Adipocytes
To study the role of Bmp4 in brown fat terminal differentiation,
we first investigated the expression of its receptors, Bmpr1a,
Bmpr1b, and Bmpr2, in brown adipocyte precursor cells. The
Bmpr1a-Bmpr2 complex, which has been shown to drive adipo-
genesis, was readily detected in these cells and was slightly
induced during differentiation. In contrast, we could not detect
Bmpr1b (Figures 1A and 1B). Next, we investigated the correla-
tion between the expression of the receptors and the activation
of Bmp4 signaling. To this end, we treated brown pre-adipocytes
with different doses of recombinant Bmp4 and quantified
the activation of canonical Smad signaling. We could show
that Bmp4 was able to fully promote the phosphorylation of
Smad1/5/8 at the dose of 5–10 ng/ml (Figure 1C), a much lower
concentration than the one used to promote commitment (Tang
et al., 2004).
Having demonstrated active Bmp4 signaling in brown pre-
adipocytes, we next investigated the effect of Bmp4 on terminal
differentiation. Classical brown differentiation induction medium
(DIM) was able to promote differentiation, while Bmp4 alone
could not (Figure 1D). In combination, Bmp4 was able to further
promote lipid storage over DIM from day 4 of differentiation on-
ward (Figures 1E and 1F). Indeed, Bmp4 stimulated the expres-
sion of adipogenic markers such as Ppar-g and Ap2 (Figure 1G)
but reduced Ucp1 protein levels (Figure 1G). This evidence sug-
gests that Bmp4 shifts the terminal differentiation of brown pre-
adipocytes toward a white-like phenotype, as corroborated by(E and F) Oil red O staining of brown pre-adipocytes at 4 and 6 days after indu
quantification of lipid content expressed as a.u. (F) (n = 6).
(G) Protein level quantification by western blot of adipogenic markers (Ppar-g a
adipocytes.
(H) qRT-PCR analysis of brown-fat-selective genes in brown pre-adipocytes at 6 d
of 10 ng/ml Bmp4 (n = 3). See also Figure S1.
Data are expressed as mean + SD. *p < 0.05.the finding that Bmp4 blunted the expression of other brown fat
markers such as Prdm16, Pgc1-a, Ppar-a, Cidea, and Bmp8b,
while inducing the expression of white fat genes such as Resistin
(Figures 1H and S1). Interestingly, Bmp4 reduced the expression
of Ppar-g2 while inducing the expression of Ppar-g1 (Figure S1).
Taken together, our data show that Bmp4 promotes lipid storage
during the terminal differentiation phaseof brownpre-adipocytes
while inducing a shift of the brown-fat gene expression pattern
toward a white-like adipocyte expression pattern.
In line with the above findings, not only the basal expression
but also the cAMP-stimulated expression of Ucp1, Pgc1-a,
and Dio2 was significantly reduced in the presence of Bmp4
(Figure 2A). Indeed, Bmp4 treated cells showed a shift from
uncoupled to coupled respiration when normalizing to basal
levels (Figures 2B and 2C), which was more pronounced after
cAMP treatment (Figures 2D and 2E). Bmp4 was able to blunt
not only cAMP-induced lipolysis but also lipolysis stimulated
by isoproterenol, forskolin, and IBMX (Figure 2F). Finally, Bmp4
could reduce the acute increase in the oxygen consumption
rate (OCR) promoted by cAMP (Figure 2G). Taken together, our
results demonstrate that exposure of brown pre-adipocytes
to Bmp4 during the terminal differentiation phase leads to a
reduced thermogenic capacity.
Next, we showed that Bmp4 treatment led to a reduced
expression of the mitochondrial free fatty acid transporter ma-
chinery (Cpt1-b, Cpt2, and Crat) (Figure 3A). In addition, the
expression of all components of the b-oxidation machinery,
with the exception of Acadl, was reduced by Bmp4 treatment
(Figure 3B). Thus, a lower dose of etomoxir (a specific inhibitor
of Cpt1) was required to reduce total respiration by 50% (Fig-
ure 3C). Moreover, the administration of exogenous free fatty
acids (FFAs) in the formof palmitate resulted in ablunted increase
in the OCR in Bmp4-treated cells (Figure 3D). Notably, treatment
with etomoxir was able to restore the OCR to basal levels in con-
trol cells, indicating that the increase in the OCR after palmitate
injection was not due to uncoupling of the mitochondrial mem-
brane. In Bmp4-treated cells, etomoxir reduced the OCR below
basal levels (reduced oxidation of endogenous FFAs), which is
in line with the observed reduced levels of Cpt1-b.
To assess the maximal fatty acid oxidation (FAO) capacity,
we first treated the cells with XF medium or etomoxir and then
challenged the cells with the mitochondrial uncoupler FCCP
to induce maximal metabolization of fatty acids, glucose, and
amino acids for ATP production. By subtracting the effect of
FCCP on cells treated with XF medium versus cells treated
with etomoxir, we could quantify the OCR devoted to maximal
FAO. As shown in Figures 3E and 3F, Bmp4was able to substan-
tially reduce also the maximal FAO of endogenous FFAs.
Following FAO, the resulting acetyl-coenzyme A (acetyl-CoA)
enters the tricarboxylic acid (TCA) cycle to produce NADH andction of adipogenesis by DIM with different doses of Bmp4 (E), and relative
nd Ap2), Ucp1, and g-tubulin at day 4 and 6 of differentiation of brown pre-
ays after the induction of adipogenesis by DIM in the absence (Ctrl) or presence
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Figure 2. Bmp4 Impairs the Acquisition of the Brown Fat Thermogenic Capacity
Brown pre-adipocyteswere differentiated tomature adipocyte by treatment with differentiation inductionmedium (DIM) in the absence (Ctrl) or presence of 10 ng/
ml Bmp4 for 6 days.
(A) qRT-PCR analysis of brown fat thermogenic genes in mature adipocytes with and without 1 mM cAMP for 4 hr (n = 3).
(B and C) Oxygen consumption rate (OCR) kinetics expressed as percentage of baseline in mature adipocytes before and after sequential injection of oligomycin
(OLIG) and rotenone/antimycin A (Rtn/AA) (B), and quantification of basal coupling and uncoupling respiration calculated as area under the curve (AUC) (C)
(n = 10).
(D and E) Measurement of OCR kinetics as percentage of baseline after sequential injection of OLIG and Rtn/AA in mature adipocytes pre-treated with 1 mM
cAMP for 24 hr (D), and quantification of stimulated coupling and uncoupling respiration expressed as AUC (E) (n = 10).
(F) Lipolytic activity in mature adipocytes stimulated with isoproterenol (ISO), cAMP, forskolin (FSK), and 3-isobutyl-1-methylxanthine (IBMX) for 4 hr (n = 6).
(G) Measurement of OCR kinetics as percentage of baseline in mature adipocytes before and after 1mM cAMP stimulation (n = 10).
Data are expressed as mean + SEM. *p < 0.05. Lowercase letters indicate significant difference between groups. p < 0.05.FADH2. In the presence of Bmp4, genes of the TCA cycle were
downregulated and citrate synthase activity was impaired (Fig-
ures 3G and 3H).2246 Cell Reports 16, 2243–2258, August 23, 2016Since the electron transport chain (ETC) is the final acceptor of
the co-factors produced by FAO and TCA, we next quantified the
expression of different components of the ETC. Treatment with
Figure 3. Bmp4 Reduces Fatty Acid Oxidation, Krebs Cycle Capacity, and Mitochondria Activity
Brown pre-adipocytes were differentiated to mature adipocyte by treatment with differentiation induction medium (DIM) in the absence (Ctrl) or presence of
10 ng/ml Bmp4 for 6 days.
(A and B) qRT-PCR analysis of mitochondrial genes involved in fatty acid uptake (A) and b-oxidation (FAO) (B) in mature adipocytes (n = 3). See also Figure S1.
(C) Determination of the concentration of etomoxir (ETO) required to reduce total respiration by 50% in control and Bmp4 differentiated adipocytes (n = 4).
(legend continued on next page)
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Bmp4 led to a reduction in mRNA expression of members of the
five complexes of the ETC (Figure 3I). To elucidate whether the
negative effect of Bmp4 on mitochondrial activity (uncoupled
respiration, FAO, TCA, and ETC) was linked to reduced mito-
chondrial content, we quantified the expression of genes known
to be involved in mitochondrial biogenesis. Bmp4 treatment
reduced the expression of Pgc1-a, Pgc1-b, Tfam, and Err-a (Fig-
ure 3J). While the expression of Pgc1-a was reduced only late in
the terminal differentiation phase, the expression of Pgc1-b was
reduced from day 3 onward (Figure S1). Pgc1-a, but not Pgc1-b,
is important for thermogenesis, while the reduced expression
of either Pgc1-a or Pgc1-b is sufficient to impair mitochondrial
biogenesis (Uldry et al., 2006). In line with the gene expression
data, Bmp4 reduced mitochondrial content as shown by
qRT-PCR analysis (Figure 3K) and green-MitoTracker staining
(Figure 3L). As a consequence, extra-respiratory capacity was
reduced by Bmp4 (Figure 3M). Finally, normalization by Cox-II
(a mitochondrial gene codified by the mitochondrial genome)
of some of the mitochondria genes codified by the nuclear
genome resulted in a value lower than 1 (Figure 3N), indicating
that the reduced expression of thermogenic and OX-PHOS
genes observed in Bmp4-treated cells cannot be considered
only an indirect effect (i.e., by reduction of mitochondrial
content).
Taken together, our results demonstrate that Bmp4 negatively
impacts the bioenergetics of brown fat cells by dissociating the
differentiation of brown pre-adipocytes from the acquisition of
a mature brown fat phenotype as indicated by reduced expres-
sion of brown-fat-selective genes, TCA cycle and ETC genes,
lipolytic activity, uncoupling respiration, FAO, and mitochondrial
content.
Bmp4 Promotes Lipid Storage into Bigger Lipid Droplets
as a Consequence of Reduced Basal Lipolysis
After demonstrating that treatment of brown pre-adipocytes with
Bmp4 led to a shift toward a white-like adipocyte phenotype, we
next aimed to elucidate the mechanism behind this switch. Our
data indicate that Bmp4 is responsible for an increased accumu-
lation of lipids during the terminal differentiation phase (Fig-
ure 1E), while reducing the acquisition of a brown phenotype.
To study whether the increased accumulation of triglycerides
(TGs) is due to a higher number of adipocytes or rather an in-
crease in lipid droplet (LD) size, we quantified the number of(D) Oxygen consumption rate (OCR) kinetic expressed as percentage of baseline
(100 mM) (n = 10).
(E and F) OCR kinetic expressed as percentage of baseline in mature adipocytes b
(trifluoromethoxy)phenylhydrazone (FCCP), and rotenone/antimycin A (Rtn/AA) (E
(F) (n = 5).
(G and H) qRT-PCR analysis of representative tricarboxylic acid (TCA) cycle gen
citrate synthase (Cs) activity (H) (n = 6).
(I) qRT-PCR analysis of representative genes of the five complexes of the mitoc
Figure S1.
(J) qRT-PCR analysis in mature adipocytes of genes involved in mitochondrial bi
(K and L)Mitochondrial content quantification by qRT-PCR in brown pre-adipocyte
staining at day 6 (N) (n = 3).
(M) Maximal mitochondrial activity after (FCCP) injection (n = 10).
(N) Normalization of representative nuclear mitochondrial genes to Cox-II (n = 3)
Data are expressed as mean + SD. *p < 0.05.
2248 Cell Reports 16, 2243–2258, August 23, 2016differentiated cells in the presence or absence of Bmp4. We
could show that this increase in lipid content could be attributed
not to an increase in the number of differentiated adipocytes
(Figure 4C), but rather to an increase in the size of LDs (Figures
4A and 4B). We did not observe changes in the expression of
LD-coating proteins (Figure S1), but we could show that at the
time of LD formation, Bmp4 reduced the expression of Hsl and
Mgl, but not of Atgl (Figures 4D and S1). Furthermore, phosphor-
ylation of Hsl at ser660, which has been linked to the activation
of lipolysis, was reduced by Bmp4 treatment (Figure 4E). The
Bmp4-mediated reduction of Hsl and Mgl expression and activ-
ity resulted in a reduced basal lipolysis (Figure 4F). Phosphoryla-
tion of Hsl at ser660 is induced by PKA upon cAMP activation. As
Bmp4 did not reduce the levels of cAMP (Figure S2A), we pro-
pose that Bmp4 does not regulate the pathways that converge
on cAMP for the promotion of Hsl phosphorylation. This is sup-
ported by our finding that phosphorylation of Akt was unchanged
(Figure S2B) and that PKA activity was not altered upon Bmp4
treatment (Figure S2C). Finally, we could exclude that de-regula-
tion of inflammatory and apoptotic processes is the reason for
altered lipolysis, as we did not observe any changes in the
expression of genes involved in these processes (Figure S1).
Indeed, treatment with LDN-193189, a potent inhibitor of the
BMP4-mediated SMAD1, SMAD5, and SMAD8 activation, at a
sub-maximal dose of 1 mM (see Figure 5D), as well as small inter-
fering RNA (siRNA)-mediated knockdown of Smad4 (siSmad4),
promoted the expression of Hsl and rescued the negative effect
of Bmp4 (Figures S2D and S2E). Taken together, our results
indicate that Bmp4 decreases Hsl activity in part by reducing
its expression via the Bmp4-Smad signaling pathway.
To elucidate whether lipogenesis contributed to increased LD
size, we analyzed the expression of enzymes involved in TG
re-esterification (Gyk, Dgat1, and Dgat2) and de novo lipogensis
(Acc1, Acc2, and Fasn). Bmp4 treatment reduced rather than
induced the expression of the analyzed genes (Figure S1).
Furthermore, Bmp4 promoted the phosphorylation of Acc1 at
ser79, which resulted in inactivation of the enzyme (Figure 4G).
In our model, the appearance of LDs at day 3 precedes the in-
duction of the expression of brown fat genes at day 4 (Figure S1),
which suggests that a link exists between these two events, as
proposed previously (Nishino et al., 2008). Thus, at day 4, lipo-
lytic products from basal lipolysis might activate Ppars to shape
the acquisition of the brown phenotype. As shown in Figure 5A,in mature adipocytes after sequential injections of palmitate (PALM) and ETO
efore and after sequential injection of ETO (or XFmedium), carbonyl cyanide-4-
), and quantification of maximal FAO calculated as area under the curve (AUC)
es in mature adipocytes (G) (n = 3) (see also Figure S1), and quantification of
hondrial electron transport chain (ETC) in mature adipocytes (n = 3). See also
ogenesis (n = 3). See also Figure S1.
s at days 2, 4, and 6 of differentiation (M) and representative greenMitoTracker
.
Figure 4. Bmp4 Promotes Bigger Lipid
Droplet Formation by Reducing Lipolysis
(A–C) LD staining by LD540 in brown pre-adipo-
cytes at 3, 4, 5, and 6 days after induction of adi-
pogenesis by the differentiation induction medium
(DIM) in the absence (Ctrl) or presence of 10 ng/ml
Bmp4 (A), classification of LD size in classes (B),
and evaluation of the rate of differentiation (C)
(n = 6). Scale bar, 50 mM.
(D) Protein level quantification by western blot
of Hsl, Atgl and g-tubulin in brown pre-adipocytes
3, 4, 5, and 6 days after induction of adipogenesis
by DIM with and without 10 ng/ml Bmp4.
(E) Protein level quantification by western blot of
pHslser660 and g-tubulin in brown pre-adipocytes
at confluence (day 0) and 2,4,6 days after induc-
tion of adipogenesis by DIM with and without
10 ng/ml Bmp4. Cells were harvested 1 hr after
Bmp4 treatment.
(F) Basal lipolytic activity of brown pre-adipocytes
at 5 and 6 days after induction of adipogenesis by
DIM in the absence (Ctrl) or presence of 10 ng/ml
Bmp4 (n = 6) Results are expressed as a.u. (n = 6).
(G) Protein level quantification by western blot of
pAcc1ser79, Acc1, and g-tubulin during the terminal
differentiation of brown pre-adipocytes with DIM in
the absence or presence of 10 ng/ml Bmp4.
Data are expressed as mean + SD. *p < 0.05. See
also Figure S2.the reduced lipolysis through Bmp4 signaling would conse-
quently be responsible for reduced Ppar activation and, there-
fore, impaired brown phenotype development. To corroborate
this hypothesis, we treated cells with Bmp4 just before LD
formation, which resulted in a blunted expression of brown fat
genes comparable to the chronic treatment (Figure 5B). This
observation suggests that the effect of Bmp4 is linked not toCell Repthe onset of differentiation of brown fat
precursor cells but rather to the moment
when LDs form and the following basal
lipolysis is required for the generation of
Ppar ligands. To further substantiate this
hypothesis, we treated Bmp4-differenti-
ating cells with rosiglitazone before LD
formation. By inducing Ppar activity via
the exogenous addition of rosiglitazone,
we were able to partially rescue gene
expression of some brown adipocyte
markers (Figure 5C). Ucp1 expression
was not restored upon rosiglitazone treat-
ment, suggesting that other mechanisms
must be involved in this process. In
contrast, treatment with LDN-193189
during differentiation of brown pre-adipo-
cytes led to a dose-dependent increase in
Ucp1 and was able to completely rescue
the effect of Bmp4 on Ucp1 expression at
the two highest does tested (Figure 5D).
In addition, siRNA-mediated knockdown
of Smad4 led to an induction of a brownadipocyte phenotype (Figure S3D). These findings suggest a
composite regulation of Ucp1 expression by Bmp4 via Smad
signaling and possibly in part through the regulation of Ppar
activity.
Treatment with Bmp4 during differentiation of brown pre-
adipocytes resulted in a reduced activation of Smad signaling
over time (Figure S3A). This suggests the presence of a Bmp4orts 16, 2243–2258, August 23, 2016 2249
Figure 5. Effect of Bmp4 on Brown Fat Gene Expression and Partial Rescue by Rosiglitazone and LDN-193189 Treatment
(A) PPRE-luciferase (PPRE-luc) assay in brown pre-adipocytes 4 days after induction of differentiation in the presence of different concentrations of Bmp4 (n = 8).
Results are expressed as a.u.
(legend continued on next page)
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feedback mechanism based on the production of Bmp4 inhibi-
tors. Indeed, we demonstrated that Bmp4 promoted the expres-
sion of its own antagonists Gremlin 1 and 2 (Grem1 and Grem2)
as well as Noggin (Nog) (Figure S3B). Moreover, treatment of
differentiating brown pre-adipocytes with Grem1 or siSmad4 re-
sulted in the induction of the expression of brown fat genes (Fig-
ures S3C and S3D). Finally, we could show that the expression of
Bmp4 and its inhibitors Grem1 and Grem2 is dramatically
reduced during differentiation (Figure S3E). Taken together, our
observations indicate that the Bmp4-Smad signaling impairs
the acquisition of a brown phenotype and is then reduced during
differentiation. Moreover, brown adipocytes can sense Bmp4
levels and promote processes to counteract its negative effects
on the acquisition of a brown phenotype.
Bmp4 Impairs BAT Function In Vivo
Next, we investigated whether Bmp4 could also directly affect
mature brown fat cells to develop a more white-like adipocyte
phenotype. To this end, we first quantified the activation of the
canonical Smad signaling pathway in mature brown adipocytes.
Bmp4 was able to induce the transduction of the Smad signaling
via Smad1/5/8 with a full activation at a dose of 5–10 ng/ml (Fig-
ure S4A). Furthermore, treatment of mature brown adipocytes
with Bmp4 prevented the expression of Ucp1, Pgc1-a, and
Dio2 under both basal and isoproterenol-induced conditions
(Figure S4B). This resulted in reduced oxygen consumption (Fig-
ure S4C). Interestingly, isoproterenol treatment dramatically
decreased the levels of Bmp4 (Figure S4D). Furthermore,
although Bmp4 is particularly enriched in the stromal vascular
fraction (SVF) of BAT (Figure S4E), it is also present in mature ad-
ipocytes, where its expression is significantly reduced upon cold
stimulation (Figure S4F). Thus, our results suggest that Bmp4 not
only affects the terminal differentiation of brown fat precursors to
generate a cell with a more white-like adipocyte phenotype, but
also can induce mature brown fat cells to acquire such a pheno-
type. Moreover, because Bmp4 expression is reduced upon
cold stimulation and in response to b-adrenergic stimulation,
it might function as a physiological regulator of BAT-induced
thermogenesis.
To confirm that Bmp4 can impair BAT function in vivo,
we generated an adenovirus (i.e., AdBmp4) (Figure S5A) to
selectively overexpress Bmp4 in inter-scapular BAT (iBAT) of
C57BL6 mice. Expression of Bmp4 was restricted to iBAT and
could not be detected in other tissues (Figures S5B and
S5F). Ectopic expression of Bmp4 resulted in 2- to 3-fold higher
expression levels over endogenous levels (Figure 6A). AdBmp4-
treated mice did not show higher expression of inflammation
markers compared to AdLacZ mice (Figure S5C). In line with
the in vitro data, we observed activation of the canonical Smad(B) Gene expression analysis by qRT-PCR of adipogenic and brown fat genes d
induction medium (DIM) in the absence (Ctrl) or presence of 10 ng/ml Bmp4 fo
undifferentiated brown pre-adipocytes. See also Figures S6 and S7.
(C and D) Gene expression analysis by qRT-PCR of brown fat metabolic genes
the absence (Ctrl) or presence of 10 ng/ml Bmp4 and/or 1 mM rosiglitazone (RSG
Bmp4, RGS, and LDN-193283 was from days 2 to 6. (n = 3). Data are expressed a
p < 0.05.
See also Figure S3.signaling and reduced expression of Ucp1, Hsl, and pHslser660
(Figure 6A) and an increased LD size in iBAT (Figure 6D). Further-
more, we could show decreased levels of genes involved in
FAO, the TCA cycle, and the ETC (Figure 6B). Interestingly,
although we did not observe changes in body weight 1 week af-
ter adenovirus administration, we noticed a shift in body compo-
sition from lean to fat in AdBmp4-treated mice (Figure 6C), which
might be explained by a slight expansion of iBAT mass (Fig-
ure 6C) due to increased lipid storage (Figure 6D). After 24 hr
of cold stimulation, AdBmp4 mice maintained bigger LDs, and
the expression of Ucp1 and Pgc1-a was reduced when
compared to AdLacZ mice (Figures 6D and 6E). As a conse-
quence, core iBAT temperature was lower in AdBmp4 mice at
room temperature (R.T.) and after 24 hr of cold exposure (Figures
6F and 6G). This effect was even more pronounced after 7 days
of cold exposure, when iBAT from AdBmp4-treated mice still
maintained bigger LDs and lower Ucp1 levels compared control
mice (Figures S5D and S5E). In line with these results, iBAT-
selective ectopic expression of Bmp4 (Figure S5F) resulted in
reduced oxygen consumption and energy expenditure during
the dark phase (Figure S5G), without any increase in serum
Bmp4 levels (Figure S5H).
Since Bmp4 is widely expressed (Figures 7H and 7I), we also
analyzed its effects on metabolism in a systemic manner. There-
fore, we performed intravenous (i.v.) injections of Ad-Bmp4
into mice. This led to an overexpression of Bmp4 in the liver,
but not in iBAT (Figure S5I), and an increase in oxygen consump-
tion and energy expenditure (Figure S5L), with no increase in
serum Bmp4 levels (Figure S5M). These observations suggest
that Bmp4 can either reduce or increase energy metabolism in
a cell-context-dependent manner.
Bmp4 Is Enriched inWhite Adipose Tissue andPositively
Correlates with Obesity
In line with the fact that Bmp4 can impair brown fat cell recruit-
ment and function by shifting adipocyte development toward a
white phenotype, we found a significantly lower expression of
Bmp4 in iBAT compared to epididymal WAT (eWAT) (Figure 7A).
Interestingly, the expression of Bmp4 in inguinal WAT (iWAT), a
fat pad that can acquire a brown-like phenotype upon chronic
Ppar-g activation by rosiglitazone (Ohno et al., 2012), was
similar to that observed in iBAT (Figure 7A). Therefore, we inves-
tigated the capacity of subcutaneous-derived adipocyte precur-
sors to form brite adipocytes in response to rosiglitazone when
Bmp4 was present. We observed that Bmp4 was able to blunt
the browning effect of rosiglitazone while promoting the expres-
sion of white-enriched genes such as leptin and resistin (Fig-
ure S6A). In addition, oxygen consumption was blunted in the
presence of Bmp4 (Figure S6B), suggesting that Bmp4 canuring the terminal differentiation of brown pre-adipocytes with differentiation
r different time frames as indicated (n = 3). n.d., not detectable. Pre-adip are
in brown pre-adipocytes at 6 days after induction of adipogenesis by DIM in
) (C) and different concentration of LDN-193189 for 6 days (D). Treatment with
s mean + SD. Lowercase letters indicate significant difference between groups.
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Figure 6. Bmp4 Blunts the Metabolic Program of Brown Adipocytes In Vivo
8- to 10-week-old C57BL/6 male mice were injected with adenovirus for Bmp4 and LacZ (AdLacZ and AdBmp4) in the interscapular brown adipose tissue (iBAT)
and sacrificed after 8 days or 9 days when cold-exposed for 24 hr.
(A) Protein level quantification by western blot of Bmp4, Smad1, pSmad1/5/8, Hsl, pHSLser660, Ucp1, and g-tubulin from iBAT of AdLacZ and AdBmp4 mice
(n = 5).
(legend continued on next page)
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impair the recruitment of both classical brown adipocytes and
brite adipocytes.
Since it is known that Bmp4 can commit MSCs to the adipo-
cyte lineage, we used a combination of differentiation induction
media (DIM) and Bmp4 exposure times to investigate the role of
Bmp4 in promoting the commitment of MSCs into a white-like or
brown-like adipocyte (Figure S7). To this end, we employed the
C3H10T1/2 cell line, which is a reliable and accepted cell model
system to study adipocyte commitment (Bowers et al., 2006;
Tang et al., 2004). As previously reported, the formation of
mature white adipocytes using a white DIM (WDIM) required a
prior commitment of the MSCs, which could be achieved by
pre-treatment with Bmp4 (Tang et al., 2004) (Figure S7A). Similar
to the WDIM, pre-treatment of MSCs with Bmp4 followed
by BDIM treatment resulted in an enhanced differentiation
compared to BDIM alone (Figure S7B). However, when we
extended the treatment with Bmp4 to post-committed MSCs
during the terminal differentiation phase, we observed, in agree-
ment with our previous results, that the expression of mitochon-
drial and brown fat genes was blunted in the presence of Bmp4
(Figure S7C).
The fact that Bmp4 can switch the brown adipocyte to awhite-
like adipocyte phenotype, coupled to recent findings indicating
that obesity is inversely correlated with the amount of active
brown fat, led us to quantify the levels of Bmp4 in this context.
We could show that in iBAT of ob/ob mice, the expression of
Bmp4, Bmpr1a, and Bmpr2 was higher than in wild-type mice
(Figure 7B). Moreover, we also found an increased expression
of Bmp4 and Bmpr1a in iBAT during aging (Figure 7C), which
has been shown to correlate with a reduction in size and activity
of BAT (Saito et al., 2009; Yoneshiro et al., 2011). Taken together,
these findings suggest that Bmp4 has a physiological role in
BAT, where it might function as an inhibitor for thermogenic
function under basal conditions.
We next investigated the relevance of BMP4 signaling in
human subjects. We could show that the expression of BMP4
was lower in deep neck BAT compared to the adjacent subcu-
taneous WAT of patients that underwent neck surgery for
nontoxic nodular goiter or lateral cervical cyst (Figure 7D).
Also, we could demonstrate that obese subjects tend to have
higher levels of circulating BMP4 than lean subjects. Interest-
ingly, BMP4 levels increased dramatically in individuals with
impaired glucose tolerance and type 2 diabetes (Figure 7E),
and serum Bmp4 levels were associated with adipocyte size
and whole-body insulin sensitivity (Figures 7F and 7G). In addi-
tion, by using stepwise regression analysis, we could show
that 2-hr glycemia is the best predictor of circulating BMP4, ac-
counting for 43% of its variability (R2 = 0.428; p < 0.001). The
M-value explained 17% of the variability (R2 = 0.60; p < 0.01),(B) qRT-PCR analysis of metabolic genes in iBAT of AdLacZ and AdBmp4 mice
(C) Evaluation of body weight, iBAT mass, and lean and fat mass by MRI (n = 5).
(D) H&E sections and immunohistochemistry for Ucp1 protein levels in iBAT of r
AdBmp4. Scale bar, 100 mM.
(E) qRT-PCR analysis of Ucp1 and Pgc1-a in iBAT of AdLAcZ and AdBmp4 mice
(F and G) Representative thermal images of AdLacZ and AdBmp4 mice at R.T. a
(n = 5).
Data are expressed as mean + SEM. *p < 0.05. Lowercase letters indicate a signthe extramyocellular lipid content contributed 11% (R2 = 0.71;
p < 0.01), BMI predicted 6% (R2 = 0.77; p < 0.05), and subcu-
taneous adiposity (R2 = 0.82; p < 0.05) contributed to circulating
BMP4 variability by 5% (R2 = 0.82; p < 0.05). In total, the entire
model could explain 82% of BMP4 variability in our cohort,
comprising a continuum from metabolic healthy to type 2 dia-
betic patients. Furthermore, the level of glucose intolerance
(2-hr glycemia in oral glucose tolerance test (oGTT); p < 0.001),
ectopic lipid accumulation (extramyocellular lipid content;
p < 0.001), insulin sensitivity (M-value in EHC; p < 0.01),
subcutaneous adiposity (p < 0.01), and adipocyte hypertrophy
(p < 0.05) could independently of age explain 43%, 41%, 31%,
33%, and 16% of BMP4 variability, respectively (Table S1).
Taken together our results show that Bmp4 is increased in
obesity, especially when hypertrophic adiposity is observed,
and that Bmp4 signaling itself can influence both brown fat cell
formation as well as the mature brown adipocyte phenotype.
DISCUSSION
Originally identified as a bone-forming and development factor,
Bmp4 was shown to promote commitment of MSCs into the adi-
pogenic lineage (Bowers et al., 2006; Huang et al., 2009; Tang
et al., 2004). Aside from this aspect, its role in brown adipocyte
formation has not been studied in great detail. Moreover, while
other members of the BMP family, such as Bmp7, Bmp8b, and
Gdf5, have been reported to affect energy homeostasis by regu-
lating the metabolic program of mature brown adipocytes (Hinoi
et al., 2014; Townsend et al., 2012; Whittle et al., 2012), insights
into the role of BMP4 in this context are missing. Since BMP4
signaling has been linked to obesity (Bowers and Lane, 2007;
Bo¨ttcher et al., 2009), we sought to investigate its role in brown
adipocyte recruitment and function.
We could demonstrate that Bmp4 was able to reduce the
expression of brown-fat-selective genes, uncoupled respiration,
basal and stimulated lipolysis, FAO, TCA activity, and mitochon-
drial content, concomitant with an increase in LD size. Notably,
the pattern of intracellular lipid storage is closely related to the
metabolic characteristics of adipocytes, where bigger LDs are
linked to a white phenotype while smaller LDs are linked to a
brown phenotype. Smaller LDs result in an enhanced total sur-
face area of LDs, which allows an easier access of lipases to
the stored lipids with a consequently greater rate of basal as
well as induced lipolysis (Nishino et al., 2008). Indeed, it has
been shown that high rates of lipolysis are required to foster
the activation of members of the PPAR family via lipolytic prod-
ucts to the extent of promoting and maintaining a brown adipo-
cyte phenotype (Ahmadian et al., 2011; Contreras et al., 2014;
Mottillo et al., 2012; Nedergaard et al., 2005; Zhou et al., 2014).(n = 5).
oom temperature (R.T.) and 24-hr cold-exposed mice treated with AdLacZ or
at R.T. and after 24-hr cold exposure (n = 5).
nd after 24-hr cold exposure (F), and temperatures adjacent to iBAT depot (G)
ificant difference between groups. p < 0.05. See also Figures S4 and S5.
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Both Ppar-a and Ppar-g have been shown to increase mito-
chondrial copy number as well as the expression of Ucp1,
Mcad, and Cpt1-b (Bogacka et al., 2005). Furthermore, chronic
activation of Ppar-g by rosiglitazone promotes browning of
WAT (Ohno et al., 2012). The suggested mechanisms include
the modulation of its acetylation status (Qiang et al., 2012) and
its interaction with co-activators that are particularly enriched
in BAT (e.g., Pgc1-a, Prdm16) (Fisher et al., 2012; Seale et al.,
2011). From a physiological point of view, BAT is chronically acti-
vated by a sympathetic tone, which is necessary to sustain a
constant basal lipolytic rate for activation of Ppar-g (Contreras
et al., 2014). In line with the importance of having a constant
basal lipolysis for the development and maintenance of a brown
phenotype, studies on theAtgl-deficientmice have shown a con-
version of BAT into a white-like tissue with bigger LDs and
reduced expression of brown-fat-selective genes, a phenotype
that could be rescued by activation of Ppar-g through rosiglita-
zone (Ahmadian et al., 2011; Haemmerle et al., 2011). In this
context, our data indicate that Bmp4 can promote storage of
TGs into bigger LDs as a consequence of a reduced Hsl expres-
sion and thereby reduced activity rather than an increase in de
novo lipogenesis or TG re-esterification. The observed reduction
in lipogenesis is in line with the phenotype described in Hsl defi-
cient mice, which shows reduced re-esterification and de novo
lipogenesis, a consequence of blunted basal lipolysis to avoid
an excessive accumulation of lipids (Zimmermann et al., 2003).
In our model, the appearance of bigger LDs starts to become
evident at day 4 of terminal differentiation, which coincides with
the moment when the brown phenotype starts to manifest.
Notably, this is also the moment when Hsl becomes phosphory-
lated, possibly to provide the ligands for Ppars to promote the
acquisition of the brown phenotype.We demonstrate by ablation
of Smad4 expression and pharmacological inhibition that Bmp4,
through regulation of Smad signaling, controls brown adipocyte
gene expression. Since Smad4 is a co-Smad required for the ac-
tivity of all the other Smads involved in Bmp4 signaling (1, 5, 6, 7,
and 8), the regulatory or inhibitory Smad, which is directly
involved in Bmp4 signaling, remains to be identified. A second
regulatory mechanismmight involve the regulation of Ppar activ-
ity through the reduction of lipolysis by Hsl. This hypothesis is
supported by our findings that treatment with Bmp4 starting at
day 2 or 4 of terminal differentiation can blunt the expression
of brown fat selective genes in a manner similar to chronic treat-
ment, although the exact contribution to the overall phenotype
remains to be quantified. This suggests that Bmp4 does notFigure 7. Bmp4 Is Enriched in White Adipose Tissue, Positively Corre
Intestine
(A–C) qRT-PCR analysis of Bmp4, Bmpr1a, and Bmpr2 in interscapular brown and
wild-type mice (A), in iBAT of wild-type (wt) versus ob/ob mice (B), and in iBAT o
(D) qRT-PCR analysis of BMP4, BMPR1a and BMPR2 in cleaned human paired br
samples. UCP1 expression was evaluated as a marker for the correct biopsy (n
(E) Serum BMP4 levels in lean, obese, obese pre-diabetic (pre-T2D), and obese
(F and G) Serum BMP4 levels in human subjects correlate positively with adipoc
(H and I) mRNA-sequencing expression data of BMP4 in various human (H) andmo
up, 75% percentile; down, 25% percentile.
Data are expressed as mean + SEM. *p < 0.05. Lower case letters indicate sign
circulating BMP4, adiposity and insulin sensitivity were calculated.affect the early phase of terminal differentiation but rather regu-
lates cellular function subsequent to LD formation. As it has been
shown that blocking mitochondrial function can result in the
accumulation of TGs into bigger LDs, a consequence of a
reduced flux of FFAs into mitochondria for oxidation (Lee et al.,
2013; Vankoningsloo et al., 2005), the ability of Bmp4 to reduce
mitochondrial content and activity could also account for the
observed decrease in basal and stimulated lipolysis.
In addition to the effects on the formation of functional brown
adipocytes, we could show both in vitro and in vivo that acute
administration of Bmp4 to mature brown adipocytes blunted
their metabolic function. Selective overexpression of Bmp4 in
iBAT increased local Bmp4 levels2- to 3-fold over endogenous
levels without affecting circulating levels of Bmp4, suggesting
that the observed reduction in oxygen consumption and energy
expenditure was not due to confounding factors such as central
Bmp4 effects.
We observed an increase of Bmp4 expression in iBAT during
aging and obesity, two conditions that are correlated with the
reduction of BAT mass and activity (Saito et al., 2009). Coupled
with our findings that the expression of Bmp4 in mature fat cells
was reduced upon cold stimulation or isoproterenol treatment
and that Bmp4 levels were decreased during maturation of
brown adipocytes in cell culture, it is possible that regulation of
Bmp4 levels in different physiological and pathophysiological
conditions is responsible for modulating brown fat activity and
formation. Furthermore, the observation that Bmp4 levels are
higher in eWAT than in iBAT or iWAT suggests that Bmp4 levels
might determine the ability of a tissue to form brown adipocytes.
Based on our data, endothelial cells are most likely the major
source of Bmp4, which is in line with the fact that we observed
an enrichment of Bmp4 in the SVF of iBAT. Nevertheless, as
Bmp4 expression is readily detectable also in mature cells,
Bmp4 can probably function in both an autocrine and paracrine
manner.
While our findings indicate that Bmp4 can reduce recruitment
and function of genuine brown adipocytes, it has been proposed
that Bmp4 would promote browning of WAT and a consequent
increase in energy expenditure (Qian et al., 2013). In a recent
report, Qian et al. demonstrated that Bmp4 overexpression un-
der the control of the Ap2 promoter induced the expression of
oxidative genes and promoted smaller LDs in WAT, while it led
to the formation of bigger LDs and lower expression of oxidative
genes in iBAT. Furthermore, the authors reported increased en-
ergy expenditure and protection from weight gain, which theylates with Obesity, and Is Mainly Produced in Endothelial Cells and
inguinal as well as epididymal white adipose depots (iBAT, iWAT, and eWAT) of
f aging mice (C) (n = 5–6).
own (deep neck) (BAT) and white (adjacent subcutaneous) (SAT) adipose tissue
= 9).
diabetic (T2D) patients (n = 12).
yte diameter (F) and negatively with insulin sensitivity (G) (n = 48).
use (I) tissues. Each bar represents themedian expression in RPKM. Error bars
ificant difference between groups. p < 0.05. Pearson’s correlations between
Cell Reports 16, 2243–2258, August 23, 2016 2255
attributed to iWAT browning. This last metabolic finding is in
accordance with our results from systemic Bmp4 overexpres-
sion. An explanation for this might be the use of the Ap2 pro-
moter, which results in the ectopic expression of Bmp4 not
only in the adipose tissue but also in multiple other cells, such
as macrophages and endothelial cells (Jeffery et al., 2014).
Because Bmp4 is widely expressed in various cell types, espe-
cially endothelial cells, genetic strategies to modulate Bmp4
expression are problematic, as they usually target only a small
subset of cells within a given organ. In this context, the use of
adenoviral delivery systems might be a good alternative to
modulate expression within a complete tissue (Jimenez et al.,
2013).
We and others have shown that Bmp4 is important for the
commitment of MSCs into the adipocyte lineage (Elsen et al.,
2014; Xue et al., 2014). We now extend these studies demon-
strating that in the context of a committed pre-adipocyte,
Bmp4 impairs brown adipocyte formation. Based on our findings
and published work, we propose a dual function for Bmp4, on
the one hand driving commitment of mesenchymal progenitor
cells to the adipocyte lineage and on the other hand promoting
the acquisition of a white like phenotype. This dual role in adipo-
genesis could also explain the at first glance divergent findings to
the results reported by Gustafson et al. (2015), who propose an
induction of brown adipocyte formation by BMP4 in human
adipocyte progenitor cells. Whether the action of Bmp4 is spe-
cific to the brown adipocyte and might therefore modulate the
formation of a masked brown adipocytes by mediating intercon-
version remains to be determined (Rosenwald et al., 2013) (Wang
et al., 2013).
While our data suggest that Bmp4 acts in both a paracrine and
autocrine manner, it remains unclear whether Bmp4 can also act
as an endocrine factor. We could show that the levels of circu-
lating BMP4 progressively increased from lean to obese sub-
jects. Interestingly, the level of glucose intolerance (2-hr glyemia
in oGTT) and insulin sensitivity (M-value in EHC) were the best
predictors of plasma BMP4 levels, independent of age. To our
knowledge, this is the first time that a correlation between circu-
lating levels of BMP4 and the degree of diabetes in obese and
lean subjects has been established. While these findings fit to
the observed reduction in brown fat function, they are neverthe-
less at odds with our findings that systemic overexpression of
Bmp4 leads to enhanced energy expenditure. This could be
due to cell specific effects of Bmp4 in different tissues. Further-
more, it is possible that Bmp4 levels are actually increased in
obesity as part of a compensatory reaction to enhance energy
expenditure, as it was shown for another member of the BMP
family, namely GDF5 (Hinoi et al., 2014).
Taken together, our murine and human observations suggest
that BMP4 signaling might be involved in obesity. Based on our
findings and those of others (Hinoi et al., 2014; Qian et al., 2013),
we propose that BMP4might be part of a compensatory protec-
tive mechanism to counteract obesity and its clinical complica-
tions, on the one hand by promoting the recruitment of new ad-
ipocytes in WAT depots as well as by inhibiting lipolysis to limit
excess fat storage in ectopic sites such as liver and skeletal mus-
cle, and on the other hand by increasing energy expenditure.
Further studies will be required to dissect the systemic effects2256 Cell Reports 16, 2243–2258, August 23, 2016of BMP4 and to address the question of BMP4 function in sys-
temic metabolic control.
EXPERIMENTAL PROCEDURES
Cell Culture
Immortalized mouse brown pre-adipocytes and subcutaneous pre-adipocytes
were obtained as previously described (Klein et al., 2002; Kovsan et al., 2009).
C3H10T1/2 mesenchymal stem cells were obtained from ATCC. All cells were
cultured in DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin and differentiated in rat collagen-coated plates using a DIM.
When indicated, murine recombinant Bmp4 (R&D Systems), rosiglitazone,
LDN-193189,and recombinantGrem1 (R&DSystems)were included in thediffer-
entiation medium at the final concentration of 10 ng/ml (or as indicated) 1 mM,
125–2,000 nM, and 2.5–100 ng/ml, respectively. Luciferase assays measuring
PPARactivitywere performedasdescribedpreviously (Meissburger et al., 2011).
Cellular Respiration
Cells were differentiated on rat-collagen-coated 24-well Seahorse cell culture
microplates containing DIM with or without 10 ng/ml Bmp4 until day 6. The
OCR measurements were performed at 37C using an XF24 extracellular
flux analyzer (Seahorse Bioscience). Data were exported in GraphPad Prism
for visualization and analysis.
Automated Analysis of Adipocyte Differentiation and Lipid Droplet
Size
Automated analysis was performed as described before (Meissburger et al.,
2011)
Western Blot Analysis
Primary antibodies were diluted 1:1,000 in MILK-TBS-T: Smad1, pSmad1/5/8,
Hsl, pHslSer660, Acc1, pAcc1Ser79, Akt, pAktSer473, pAktThr308, phospho-PKA
substrate, Atgl, Aco2, Acadm (Cell Signaling Technology), Bmp4 (Millipore),
g-Tubulin (Sigma). Secondary antibodies were diluted 1:10000 in MILK-
TBS-T: anti-mouse and anti-rabbit (Calbiochem).
Adenovirus Construction
Bmp4 adenovirus (AdBmp4) and LacZ adenovirus (AdLacZ) were generated
using the Viral Power Adenoviral Expression System (Invitrogen) and purified
using the Adenovirus Standard Purification ViraKit (Virapur) following the
manufacturer’s instructions.
Animals
All animal studies were approved by the veterinary office of Zurich. Male
C57BL/6 and ob/ob mice were kept on a 12/12-hr light/dark cycle in a path-
ogen-free animal facility at 23C.
Administration of Adenoviruses
8- to 10-week-old C57BL/6 male mice were anesthetized with isoflurane
(Sigma). For intra-brown adipose tissue administration, a longitudinal incision
at the interscapular region area was performed. To distribute the viruses in the
whole fat depot, each iBAT received four injections of 10 ml adenovirus solution
(109 PFU/ml) using a Hamilton syringe. For i.v. injections, 100 ml virus was
administrated via tail vein. Mice were sacrificed after 8 days when housed at
room temperature and after 9 or 15 days when cold exposed for 24 hr or
7 days, respectively.
Clinical Studies
The clinical studies were approved by the local ethics committee at the
University Hospital in Bratislava and conformed to the ethical guidelines
of the 2000 Helsinki declaration. All study participants provided witnessed
written informed consent before entering the study.
Statistical Methods
For in vitro studies, data are expressed as mean ± SD. For in vivo studies, data
are expressed as mean ± SEM. Statistical significance between groups was
determined using the Student’s t test or one-way ANOVA followed by appro-
priate post hoc tests. A p value < 0.05 was considered a statistically significant
difference. Pearson’s correlations between circulating BMP4, adiposity, and
insulin sensitivity were calculated. Stepwise multiple regression analysis was
performed (JMP, SAS) to identify clinical parameters which best predict circu-
lating BMP4 levels in human subjects. Statistical analyses were performed
using GraphPad Prism.
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